Michael Schwartz tested the toxicity of 60 different chemicals on miniature model brains developed using neural progrenitor cells grown on hydrogels. Read Full Articles Here and Here
Uncategorized
Why drug companies need human tissue- especially liver
Bill Murphy talks to the Washington Post about the ethics and importance of human tissue in drug testing and development. Read Full Article
The Canadian military wants to use stem cells to help its soldiers heal
Bill Murphy talks to Vice News about the use of stem cells in regenerative technologies capable of healing battlefield injuries Read Full Article
Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems
Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems to develop bioresorbable, implantatable devices for skeletal reconstruction and bone regeneration Watch Video Here
α/β-Peptides Could Offer Low-Cost Alternative To Antibody Drugs
Samuel H. Gellman, William L. Murphy, Katrina T. Forest, and coworkers have designed a two-helix α/β-peptide with afffinity for VEGF and demonstrated its use by inhibiting the growth of cells lining blood vessels, a process …
Researchers aim to broaden understanding of how toxins affect the body
Bill Murphy is leading a diverse team of UW-Madison researchers who received $6 million from the EPA Science to Achieve Results (STAR) program. The grant will create the Human Models for Analysis of Pathways (H-MAPs) …
WPR: “Tissue Chips” could replace animal testing
Wisconsin Public Radio interviews Bill Murphy about how organotypic tissue models developed at UW-Madison would be used to advance drug screening Listen to the Interview Here
UW-Madison lecture on Regenerative Medicine: from stem cells to new organs
UW-Madison’s “Mini Med School” course titled “Regenerative Medicine: from stem cells to new organs” features prominent UW stem cell and regenerative medicine researchers (Tim Kamp, Sean Palecek, Bill Murphy, Jamie Thomson, Sam Gubbels, Amish Raval) …
Additional $7 million grant from NIH to develop “organs on a chip” for drug screening
A multidisciplinary collaboration between James Thomson, Bill Murphy, and David Page will receive an additional $7 million in NIH funding to continue their work as part of the Tissue Chip for Drug Screening program Read …
Stem cell advances may quell ethics debate
USA Today quotes Bill Murphy in an article discussing advances in stem cell research that might quell the public debate concerning the ethics of human embryonic stem cell use Read Full Article